Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
- 30 July 2008
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 200 (1), 135-140
- https://doi.org/10.1016/j.atherosclerosis.2008.06.003
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Atherogenic Lipoprotein Particles in AtherosclerosisCirculation, 2004
- Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatmentBMJ, 2004
- Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)American Heart Journal, 2003
- Cardiovascular disease and long-chain omega-3 fatty acidsCurrent Opinion in Lipidology, 2003
- Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient MiceCirculation, 2002
- Changes in Aspects Such as the Collagenous Fiber Density and Foam Cell Size of Atherosclerotic Lesions Composed of Foam Cells, Smooth Muscle Cells and Fibrous Components in Rabbits Caused by All-cis-5, 8, 11, 14, 17-icosapentaenoic Acid.Journal of Atherosclerosis and Thrombosis, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS?The Lancet, 1978